Two SKCC PhD Students Invited To Present Research At International Meetings

Congratulations to two PhD students in Dr. Karen Knudsen’s laboratory who have been invited to speak at upcoming Keystone Symposia on Molecular and Cellular Biology!! Jennifer Jones McMann, a student in the Genetics, Genomics and Cancer Biology PhD Program, will present “Novel Action of p53 Gain-of-Function Mutation in Prostate Cancer Progression” at the Keystone Conference …


Dr. Robert Den featured on eCancerTV

Dr Den talks to ecancertv at ASTRO 2015 about a study that found a commercially available genomic classifier for prostate cancer may be able to help predict which men may benefit from additional systemic therapy after prostatectomy and salvage radiotherapy. In the interview he describes how the test was able to predict which men would …


New RO1 Award Announcement: Dr. Sue Menko

Sidney Kimmel Cancer Center Member Dr. Susan Menko, was recently award an NIH funded RO1 Grant In the grant “Repurposing Classical Death Pathways for Signaling Roles in Lens Differentiation” a Multiple PI team led by Sue Menko proposes to investigate normal signaling functions for classical apoptotic and autophagy pathways in the context of regulating crucial …


Palliative Care in Oncology Plan for PA

Margaret “Peg” O’Grady, Director of Nursing for the Department of Medical Oncology has been selected to work on a collaborative initiative of creating an oncology palliative care plan for the state of Pennsylvania. Her role at Jefferson had made her a critical stakeholder  positioned to advance oncology palliative care.  This initiative is being led by …


NIH Awards $350K for Study of Compound That Could ‘Starve’ Pancreatic Tumors

In the Curtis Building laboratories, Drs Jordan Winter, Jonathan Brody and Susan Lanza-Jacoby join forces to disrupt the energy supply of pancreatic cancer cells. Susan Lanza-Jacoby, PhD, has been awarded the National Institutes of Health Cancer Institute grant for her work with Jonathan Brody, PhD, Director of Surgical Research and Co-Director of the Jefferson Pancreas, …


PODCAST: Radiation Oncology Residency Program at TJU

                          Dr. Adam Dicker (Professor & Chairman)                          Dr. Voichita Bar Ad (Residency Program Director) On November 12th, 2015, the Department of Radiation Oncology, under the leadership of Dr. Adam P. Dicker and Dr. Voichita Bar Ad, recorded our first podcast with special focus …


Dr. Den Featured in ASCOPost: Genomic Test Identifies Patients With Prostate Cancer in Need of Intensified Salvage Therapy

Prostate cancer has been slow to catch up with breast cancer in terms of using biomarkers, but a new study represents progress in this regard. A genomic classifier called Decipher® provides important information that can be used to make treatment decisions for men with prostate cancer and a rising prostate-specific antigen (PSA) after radical prostatectomy. …


Sidney Kimmel Cancer Center Approved for a $250K Engagement Award by the Patient-Centered Outcomes Research Institute

[Philadelphia, PA]. (November 17, 2015) – A team at Thomas Jefferson University’s Sidney Kimmel Cancer Center has been approved for a Eugene Washington PCORI Engagement Award by the Patient-Centered Outcomes Research Institute (PCORI) to support the reduction of cancer disparities.   Ronald Myers, Ph.D., Director of the Division of Population Science will lead the engagement …


Examining the Cost of Cancer Treatment: Dr. Adam Dicker

Dr. Adam Dicker, a professor and chair of the Department of Radiation Oncology at Thomas Jefferson University’s Sidney Kimmel Cancer Center, was a coauthor of the ASCO guidelines. His research focuses on novel drugs, immunotherapy, and the application of precision medicine for patients with cancer. He recently spoke to us about the cost of cancer …


The Perfect Match Might Be the Imperfect One

When it comes to treating blood cancers like leukemia and lymphomas, new research shows that a half-matched donor bone marrow transplant may be just as good as a full match, in the first apples to apples type comparison of its kind. (PHILADELPHIA) – Bone marrow transplantation is a life-saving therapy for many patients with blood …


Dr. Robert Den featured in OncoTherapy Network

Genomic Classifier May Help Predict Metastasis Following Prostatectomy and SRT Clinicians may now have a better tool for guiding therapy in men with prostate cancer who have had a prostatectomy and salvage radiation therapy (SRT). Investigators calculated genomic classifier (GC) scores for 166 patients based on genomic analysis of their own tumor tissue. They found …

Page 1 of 25